Andlauer Healthcare Group (TSE:AND – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, July 31st. Analysts expect Andlauer Healthcare Group to post earnings of C$0.43 per share for the quarter.
Andlauer Healthcare Group (TSE:AND – Get Free Report) last issued its earnings results on Thursday, May 2nd. The company reported C$0.35 EPS for the quarter, missing the consensus estimate of C$0.53 by C($0.18). The firm had revenue of C$161.14 million during the quarter, compared to the consensus estimate of C$168.50 million. Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%.
Andlauer Healthcare Group Trading Up 0.2 %
Shares of Andlauer Healthcare Group stock opened at C$40.64 on Tuesday. Andlauer Healthcare Group has a 52-week low of C$36.43 and a 52-week high of C$44.76. The firm has a market capitalization of C$791.67 million, a PE ratio of 26.91 and a beta of 0.69. The company has a debt-to-equity ratio of 26.06, a current ratio of 1.94 and a quick ratio of 1.66. The company’s fifty day moving average price is C$38.81 and its two-hundred day moving average price is C$40.28.
Andlauer Healthcare Group Announces Dividend
Analyst Ratings Changes
A number of brokerages have commented on AND. CIBC cut their price target on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Royal Bank of Canada cut their target price on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating for the company in a research report on Monday, May 6th. Stifel Nicolaus lowered their price target on Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating on the stock in a research report on Monday, May 6th. TD Securities cut their price objective on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a report on Monday, May 6th. Finally, Scotiabank lowered shares of Andlauer Healthcare Group from a “strong-buy” rating to a “hold” rating in a report on Friday, June 14th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of C$49.43.
Get Our Latest Stock Analysis on AND
Insider Activity
In related news, Director Ronald Martin Skelton sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total transaction of C$61,309.95. Insiders own 1.43% of the company’s stock.
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Featured Stories
- Five stocks we like better than Andlauer Healthcare Group
- 3 REITs to Buy and Hold for the Long Term
- Survey: Top 175 Fittest Retirement Locations in America
- About the Markup Calculator
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- 3 Monster Growth Stocks to Buy Now
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.